Canopy Growth Corporation — Form 8-K Summary
Reporting date: April 7, 2021 earliest reported event; the filing was signed April 13, 2021. The filing reports Canopy Growth’s proposed acquisition of The Supreme Cannabis Company, Inc. and related investor communications.
Transaction and Key Terms
- Canopy Growth entered into an arrangement agreement to acquire all outstanding Supreme Cannabis common shares through a plan of arrangement under the Canada Business Corporations Act.
- Supreme Cannabis shareholders would receive 0.01165872 Canopy Growth common shares and C$0.0001 in cash for each Supreme Cannabis share.
- Based on the then-current share count, consideration was approximately 8.9 million Canopy Growth shares and C$76,000 in cash.
- Outstanding Supreme Cannabis restricted share units and options would generally vest and be converted or exchanged under the arrangement terms. Deferred share units would be cancelled for cash based on the applicable five-day volume-weighted average trading price.
- Canopy Growth anticipated that securities issued to Supreme Cannabis securityholders would rely on the Securities Act Section 3(a)(10) registration exemption.
Financial Metrics, Liquidity and Capital Structure
This Form 8-K does not provide revenue, profit, cash flow, margin, debt, liquidity, or other operating-performance metrics. The stated transaction consideration consists primarily of equity, with approximately C$76,000 of cash based on the share count described in the filing.
Conditions, Timing and Material Changes
- Completion is subject to Ontario Superior Court approval, any required approvals under the Competition Act (Canada), Supreme Cannabis shareholder approval, and other customary closing conditions.
- Supreme Cannabis shareholders were expected to vote at a meeting to be held as soon as reasonably practicable after the interim court order and no later than June 15, 2021.
- Approval required the affirmative vote of holders of two-thirds of Supreme Cannabis shares present in person or represented by proxy at the meeting.
- The filing does not report completion of the acquisition or provide a revised closing date.
- The filing does not present a comparable prior-period financial statement or quantify changes in Canopy Growth’s historical financial performance.
Management Commentary, Outlook and Risks
Canopy Growth furnished a press release dated April 8, 2021 and a presentation regarding the transaction. The filing contains forward-looking statements concerning the anticipated benefits, timing and completion of the arrangement, but does not provide specific financial guidance.
Key risks include failure to obtain court, regulatory or shareholder approvals; failure to satisfy other closing conditions; delays in preparing and distributing meeting materials; cannabis licensing and regulatory risks; changes in economic, political and financial-market conditions; COVID-19 impacts; anti-money-laundering compliance; legal and regulatory changes; and public opinion regarding the cannabis industry. Canopy Growth stated that it does not undertake to update forward-looking statements except as required by law.
Investor Verification Checklist
- Verify whether Supreme Cannabis shareholder, court and regulatory approvals were obtained and whether the arrangement ultimately closed.
- Confirm the final number of Canopy Growth shares and cash issued, including adjustments for options, restricted share units, deferred share units and dissenting shareholders.
- Review the arrangement agreement and subsequent filings for termination rights, fees, amendments and additional closing conditions.
- Assess the effect of the acquisition on Canopy Growth’s share count, ownership dilution, cash position and financial results.
- Review the furnished press release and presentation, while distinguishing forward-looking statements from completed transaction results.